Article Listing - Novartis Pipeline: A Good Fit But Cuts Are Expected

WELLCOME SELL-OFF SANCTIONED

11 May 1992

The Wellcome Trust has received the sanction of the UK High Court to reduce its stake in the UK-based pharmaceutical...

CELL GENESYS/MEDIMMUNE DEAL

11 May 1992

Cell GeneSys has struck a deal with MedImmune covering the licensing of the latter's antibody products targeted at treating patients...

1st QTR PROFIT UP 9% AT SMITH & NEPHEW

11 May 1992

In the first quarter of 1992 Smith & Nephew made sales of L 201.1 million ($357.2 million), up 11% on...

AUTISM TREATMENTS COMPARED

11 May 1992

A comparative study looking at the effects of the tricyclic antidepressants clomipramine and desipramine in children with autism, which is...

MIXED RESULTS FROM LATEST US QUARTERLIES

11 May 1992

Du Pont and Eastman Kodak were among the companies reporting first-quarter 1992 financial results in the past week. Both had...

FIDIA'S GM1 AND PARKINSONISM

11 May 1992

Italian company Fidia's ganglioside compound GM1 may be effective in treating and reversing the degeneration of neurons in Parkinson's disease,...

PHARMA PRODUCTION IN VIETNAM

11 May 1992

Vietnam's Minister of Health, Pham Song, has said that the country is still having to import up to 70% of...

BANGLADESH PROJECT

11 May 1992

The government of Bangladesh has launched an extended health care project that will last until 1996, reports China's Xinhua news...

CIBA-GEIGY SEEKS FOREIGN INVESTORS

11 May 1992

Swiss drugs major Ciba-Geigy will make strenuous efforts to gain more foreign investors as shareholders, according to supervisory council president,...

RHONE-POULENC RORER LOOKS EAST

11 May 1992

One of the major prospects for future business for Rhone-Poulenc Rorer GmbH based in Germany lies in eastern Europe, executive...

Showing 94181-94190 of 95586 articles